Eam Investors, LLC Syndax Pharmaceuticals Inc Transaction History

Eam Investors, LLC

  • $581 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$20.64 - $26.24 $346,277 - $440,228
-16,777 Reduced 32.16%
35,391 $900,000
Q3 2022

Nov 14, 2022
BUY
$18.51 - $24.79 $965,629 - $1.29 Million
52,168 New
52,168 $1.25 Million
Q1 2021

May 11, 2021
SELL
$19.28 - $24.59 $1.36 Million - $1.74 Million
-70,666 Closed
0 $0
Q4 2020

Feb 11, 2021
BUY
$15.1 - $26.44 $1.07 Million - $1.87 Million
70,666 New
70,666 $1.57 Million

Others Institutions Holding SNDX

# of Institutions
228
Shares Held
88.4M
Call Options Held
1.01M
Put Options Held
692K
View Full List

About Syndax Pharmaceuticals Inc

SNDX Quotes by TradingView
  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $796M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Eam Investors, LLC Portfolio

Follow Eam Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Investors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email